Obesity and PCOS: The effect of metabolic derangements on endometrial receptivity at the time of implantation

Reproductive Sciences

Volumn 22, Issue 1, 2015, Pages 6-14

  Schulte, Maureen M B ^a   Tsai, Jui He ^a   Moley, Kelle H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endometrial receptivity; implantation; metabolism; obesity; PCOS

Indexed keywords

FATTY ACID; GLUCOSE BLOOD LEVEL; INSULIN; SEX HORMONE;

ARTICLE; BLASTOCYST; DECIDUALIZATION; EMBRYO DEVELOPMENT; EMBRYONAL TISSUE; ENDOMETRIAL RECEPTIVITY; ENDOMETRIUM; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; GLUCOSE METABOLISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; MENSTRUAL CYCLE; NIDATION; OBESITY; OVARY POLYCYSTIC DISEASE; REPRODUCTION; ANIMAL; BLOOD; COMPLICATION; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; INFERTILITY, FEMALE; METABOLISM; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; RISK FACTOR;

ANIMALS; BLOOD GLUCOSE; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INFERTILITY, FEMALE; INSULIN; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 84919662867     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114561552     Document Type: Article

References (87)

1. Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011 ; 17 (2). 242-253
2. Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril. 2011 ; 96 (3). 530-535
3. Rashid NA, Lalitkumar S, Lalitkumar PG, Gemzell-Danielsson K. Endometrial receptivity and human embryo implantation. Am J Reprod Immunol. 2011 ; 66 (suppl 1). 23-30
4. Lessey BA. Assessment of endometrial receptivity. Fertil Steril. 2011 ; 96 (3). 522-529
5. Berlanga O, Bradshaw HB, Vilella-Mitjana F, Garrido-Gómez T, Simón C. How endometrial secretomics can help in predicting implantation. Placenta. 2011 ; 32 (suppl 3). S271 - S275
6. Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med. 2007 ; 25 (6). 461-475
7. Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol. 2011 ; 210 (1). 5-14
8. Kim ST, Moley KH. Regulation of facilitative glucose transporters and AKT/MAPK/PRKAA signaling via estradiol and progesterone in the mouse uterine epithelium. Biol Reprod. 2009 ; 81 (1). 188-198
9. Frolova AI, Moley KH. Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles. Reproduction. 2011 ; 142 (2). 211-220
10. Frolova AI, O'Neill K, Moley KH. Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation. Mol Endocrinol. 2011 ; 25 (8). 1444-1455
11. Frolova A, Flessner L, Chi M, Kim ST, Foyouzi-Yousefi N, Moley KH. Facilitative glucose transporter type 1 is differentially regulated by progesterone and estrogen in murine and human endometrial stromal cells. Endocrinology. 2009 ; 150 (3). 1512-1520
12. Lathi RB, Hess AP, Tulac S, Nayak NR, Conti M, Giudice LC. Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J Clin Endocrinol Metab. 2005 ; 90 (3). 1599-1606
13. Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, et al. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol. 2005 ; 19 (2). 379-390
14. Giudice LC, Dsupin BA, Irwin JC. Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. J Clin Endocrinol Metab. 1992 ; 75 (5). 1235-1241
15. Leon L, Bacallao K, Gabler F, Romero C, Valladares L, Vega M. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome. Steroids. 2008 ; 73 (1). 88-95
16. Wise LA, Rothman KJ, Mikkelsen EM, Sørensen HT, Riis A, Hatch EE. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod. 2010 ; 25 (1). 253-264
17. van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008 ; 23 (2). 324-328
18. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011 ; 29 (6). 507-513
19. Bellver J, Ayllón Y, Ferrando M, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010 ; 93 (2). 447-454
20. Luke B, Brown MB, Stern JE, et al. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011 ; 26 (1). 245-252
21. Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction. 2010 ; 140 (3). 347-364
22. Jungheim ES, Schon SB, Schulte MB, DeUgarte DA, Fowler SA, Tuuli MG. IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis. Hum Reprod. 2013 ; 28 (10). 2720-2727
23. Wattanakumtornkul S, Damario MA, Stevens Hall SA, Thornhill AR, Tummon IS. Body mass index and uterine receptivity in the oocyte donation model. Fertil Steril. 2003 ; 80 (2). 336-340
24. Bellver J, Rossal LP, Bosch E, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003 ; 79 (5). 1136-1140
25. Bellver J, Bosch E, Remohí J, Pellicer A. Evidence-based medicine is gaining momentum. Fertil Steril. 2005 ; 84 (5). 1555-1556
26. Bellver J, Pellicer A, García-Velasco JA, Ballesteros A, Remohí J, Meseguer M. Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. Fertil Steril. 2013 ; 100 (4). 1050-1058
27. Bellver J, Melo MA, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007 ; 88 (2). 446-451
28. Dessolle L, Daraï E, Cornet D, et al. Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod. 2009 ; 24 (12). 3082-3089
29. DeUgarte DA, DeUgarte CM, Sahakian V. Surrogate obesity negatively impacts pregnancy rates in third-party reproduction. Fertil Steril. 2010 ; 93 (3). 1008-1010
30. Bellver J, Martínez-Conejero JA, Labarta E, et al. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil Steril. 2011 ; 95 (7). 2335 2341 e1-2341 e8
31. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3 rd PCOS Consensus Workshop Group. Fertil Steril. 2012 ; 97 (1). 28-38. e25
32. Dor J, Itzkowic DJ, Mashiach S, Lunenfeld B, Serr DM. Cumulative conception rates following gonadotropin therapy. Am J Obstet Gynecol. 1980 ; 136 (1). 102-105
33. Macklon NS, van der Gaast MH, Hamilton A, Fauser BC, Giudice LC. The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci. 2008 ; 15 (4). 357-365
34. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003 ; 361 (9371). 1810-1812
35. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod. 2012 ; 27 (5). 1327-1331
36. Savaris RF, Groll JM, Young SL, et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab. 2011 ; 96 (6). 1737-1746
37. Aghajanova L, Velarde MC, Giudice LC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010 ; 28 (1). 51-58
38. Suikkari AM, Ruutiainen K, Erkkola R, Seppälä M. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum Reprod. 1989 ; 4 (2). 136-139
39. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002 ; 66 (2). 297-304
40. Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003 ; 88 (1). 238-243
41. Gregory CW, Wilson EM, Apparao KB, et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab. 2002 ; 87 (6). 2960-2966
42. Frolova AI, Moley KH. Quantitative analysis of glucose transporter mRNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology. 2011 ; 152 (5). 2123-2128
43. von Wolff M, Ursel S, Hahn U, Steldinger R, Strowitzki T. Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab. 2003 ; 88 (8). 3885-3892
44. Adastra KL, Frolova AI, Chi MM, et al. Slc2a8 deficiency in mice results in reproductive and growth impairments. Biol Reprod. 2012 ; 87 (2). 49
45. James DE, Brown R, Navarro J, Pilch PF. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature. 1988 ; 333 (6169). 183-185
46. Welch RD, Gorski J. Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology. 1999 ; 140 (8). 3602-3608
47. Mioni R, Chiarelli S, Xamin N, et al. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab. 2004 ; 89 (8). 4089-4096
48. Mozzanega B, Mioni R, Granzotto M, et al. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci. 2004 ; 1034: 364-374
49. Zhai J, Liu CX, Tian ZR, Jiang QH, Sun YP. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod. 2012 ; 87 (2). 29
50. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995 ; 10 (suppl 2). 14-21
51. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med. 1991 ; 325 (13). 938-948
52. Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest. 1989 ; 83 (1). 23-29
53. Steingold KA, Lobo RA, Judd HL, Lu JK, Chang RJ. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease. J Clin Endocrinol Metab. 1986 ; 62 (5). 1048-1051
54. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980 ; 50 (1). 113-116
55. Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010 ; 122 (1-3). 42-52
56. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem. 1999 ; 274 (4). 1865-1868
57. Fornes R, Ormazabal P, Rosas C, et al. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med. 2010 ; 16 (3-4). 129-136
58. Chang EM, Han JE, Seok HH, Lee DR, Yoon TK, Lee WS. Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation-in vitro fertilization-embryo transfer cycle. Clin Endocrinol (Oxf). 2013 ; 79 (1). 93-99
59. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008 ; 37 (3). 635 viii - 646 ix
60. Palin MF, Bordignon VV, Murphy BD. Adiponectin and the control of female reproductive functions. Vitam Horm. 2012 ; 90: 239-287
61. Halberg NI, Wernstedt-Asterholm L, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008 ; 37 (3). 753 x - 768 xi
62. Guerre-Millo M. Adiponectin: an update. Diabetes Metab. 2008 ; 34 (1). 12-18
63. Carmina E, Chu MC, Moran C, et al. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril. 2008 ; 89 (3). 642-648
64. Kim ST, Marquard K, Stephens S, Louden E, Allsworth J, Moley KH. Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus. Hum Reprod. 2011 ; 26 (1). 82-95
65. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001 ; 7 (8). 947-953
66. Dos Santos E, Serazin V, Morvan C, et al. Adiponectin and leptin systems in human endometrium during window of implantation. Fertil Steril. 2012 ; 97 (3). 771-778. e1
67. Takemura Y, Osuga Y, Yamauchi T, et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology. 2006 ; 147 (7). 3203-3210
68. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 2001 ; 24 (1). 89-94
69. Sir-Petermann T, Echiburú B, Maliqueo MM, et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod. 2007 ; 22 (7). 1830-1836
70. Toulis KA, Goulis DG, Farmakiotis D, et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009 ; 15 (3). 297-307
71. Agarwal N, Rice SP, Bolusani H, et al. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab. 2010 ; 95 (2). 722-730
72. Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008 ; 93 (7). 2670-2678
73. Glintborg D, Frystyk J, Højlund K, et al. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2008 ; 68 (2). 165-174
74. Palomba S, Falbo A, La Sala GB. Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2013 ; 120 (3). 267-276
75. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 2002 ; 77 (2). 209-215
76. Johnson NP, Stewart AW, Falkiner J, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007 ; 356 (6). 551-566
77. Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001 ; 86 (12). 5925-5933
78. Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2005 ; 62 (6). 644-649
79. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab. 2001 ; 86 (3). 1318-1323
80. Dumesic DA, Richards JS. Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril. 2013 ; 100 (1). 23-38
81. Giallauria F, Palomba S, Vigorito C, et al. Androgens in polycystic ovary syndrome: the role of exercise and diet. Semin Reprod Med. 2009 ; 27 (4). 306-315
82. Fauser BC, Laven JS, Tarlatzis BC, et al. Sex steroid hormones and reproductive disorders: impact on women's health. Reprod Sci. 2011 ; 18 (8). 702-712
83. Gonzalez D, Thackeray H, Lewis PD, et al. Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect?. J Clin Endocrinol Metab. 2012 ; 97 (3). 957-966
84. Du H, Sarno J, Taylor HS. HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium. Biol Reprod. 2010 ; 83 (2). 205-211
85. Satokata I, Benson G, Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature. 1995 ; 374 (6521). 460-463
86. Makrigiannakis A, Coukos G, Mantani A, et al. Expression of Wilms' tumor suppressor gene (WT1) in human endometrium: regulation through decidual differentiation. J Clin Endocrinol Metab. 2001 ; 86 (12). 5964-5972
87. Anthony FW, Mukhtar DD, Pickett MA, Cameron IT. Progesterone up-regulates WT1 mRNA and protein, and alters the relative expression of WT1 transcripts in cultured endometrial stromal cells. J Soc Gynecol Investig. 2003 ; 10 (8). 509-516